Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Clinical Phenotypes and Prognostic Heterogeneity of Mild-to-Moderate Chronic Obstructive Pulmonary Disease: A Prospective Community-Based Cohort Study.

Created on 27 Oct 2026

Authors

Fan Wu, Qi Wan, Kunning Zhou, Xiaohui Wu, Gaoying Tang, Suyin Huang, Tingting Xia, Fangyan Wu, Junfeng Lin, Guannan Cai, Yuyan Hou, Xiaoyan Huang, Xiaohuan Pan, Jian Zhang, Xianliang Zeng, Zihui Wang, Haiqing Li, Erkang Yi, Zhifeng Gao, Changli Yang, Yongqing Huang, Shuqing Yu, Lifeng Lin, Yu Deng, Nanshan Zhong, Yumin Zhou, Pixin Ran, ECOPD study investigators

Published in

Chest. Oct 26, 2026. Epub Oct 26, 2026.

Abstract

The clinical phenotypes, prognosis, and heterogeneity of mild-to-moderate chronic obstructive pulmonary disease (COPD) have not been systematically evaluated.
Do different clinical phenotypes of mild-to-moderate COPD have different prognoses?
We analysed the baseline and 3-year follow-up data of participants with mild-to-moderate COPD from a prospective community-based cohort study. Mild-to-moderate COPD was defined as a forced expiratory volume in 1 second (FEV1) / forced vital capacity ratio of < 0.70 and FEV1 ≥ 50% of the predicted value. The clinical phenotypes included respiratory symptoms, exacerbation history, emphysema, air trapping, and airway remodelling. Respiratory health outcomes included exacerbations and lung function decline over the 3-year follow-up.
Overall, 806 participants with mild-to-moderate COPD were included, of whom 712 (88%) completed the 3-year follow-up. Participants with mild-to-moderate COPD had more severe emphysema, air trapping, and airway remodelling; increased exacerbation risk; and faster annual FEV1 decline than those with preserved spirometry. The severity of airflow obstruction, respiratory symptoms, emphysema, and air trapping, as well as the eosinophilic phenotype, had low overlap in mild-to-moderate COPD. There was significant individual variation in the annual FEV1 decline rate and exacerbation incidence among participants with mild-to-moderate COPD. Emphysema and air trapping were associated with faster FEV1 decline and higher exacerbation risk. Respiratory symptoms and exacerbations in the previous year were associated with a higher acute exacerbation risk but not with faster lung function decline.
Mild-to-moderate COPD exhibited distinct clinical phenotypes with significant prognostic heterogeneity. Accurate phenotype identification is essential for targeted intervention, clinical precision management, and prognostic improvement.

PMID:
42933687
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 23
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement